GFP/Luc Reporter Cell Line - MSC

Mesenchymal stem cells (MSCs) are well-characterized, multipotent stromal cells most commonly isolated from sources such as bone marrow, adipose tissue, or the umbilical cord. Growing as plastic-adherent, spindle-shaped fibroblasts, they are defined by their remarkable ability to differentiate into diverse mesodermal lineages, including osteoblasts, chondrocytes, and adipocytes. The GFP/Luc Reporter Cell Line - MSC enhances this versatile cellular model through the stable integration of a dual-reporter system co-expressing Green Fluorescent Protein (GFP) and firefly luciferase. This precise engineering equips the cells with two distinct, complementary tracking modalities: GFP provides robust fluorescence for direct visual confirmation and optical analysis, while luciferase emits a highly quantifiable bioluminescent signal upon exposure to D-luciferin. Crucially, the engineered MSCs retain the fundamental biological properties of the parental cells, maintaining their tri-lineage differentiation potential, self-renewal capacity, and standard surface marker profile (positive for CD73, CD90, and CD105, and negative for hematopoietic markers), ensuring a biologically authentic foundation for advanced research.

The dual-reporter functionality of the GFP/Luc MSC line makes it an indispensable tool across regenerative medicine, immunology, and oncology research. In standard in vitro settings, the stable GFP expression allows researchers to visually monitor cellular morphology during long-term differentiation assays using fluorescence microscopy, and it enables precise single-cell sorting and quantification via flow cytometry. The primary advantage of this cell line, however, is realized in complex preclinical animal modeling. Because MSCs possess a unique homing ability toward sites of inflammation, tissue injury, and specific tumor microenvironments, tracking their biodistribution is critical for developing cell-based therapies. When administered to animal models, the luciferase component facilitates highly sensitive, non-invasive bioluminescence imaging (BLI). This capability allows scientists to longitudinally track the real-time systemic migration, precise tissue engraftment, and long-term survival of the administered MSCs in living subjects. As a result, this cell line is exceptionally valuable for evaluating the efficacy of stem cell therapies in wound healing, mapping tissue regeneration dynamics, and investigating stromal-tumor interactions without the need for destructive endpoint analyses.